JB Chemicals & Pharmaceuticals Balance Sheet Annual

Trade

BSE: 506943 | NSE: JBCHEPHARM | ISIN: INE572A01036 | Sector: Biotechnology & Drugs

1,750.80 +16.60 (0.96%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	88.22	26.91	1.82	3.39
Short Term Investments	377.37	192.27	1.21	668.92
Cashand Short Term Investments	465.59	269.20	57.75	697.61
Accounts Receivable- Trade Net	686.92	576.19	555.69	389.02
Total Receivables Net	687.62	604.77	618.60	412.47
Total Inventory	502.51	444.08	441.05	351.15
Other Current Assets Total	197.63	193.28	145.41	79.12
Total Current Assets	1,853.35	1,528.03	1,274.86	1,552.60
Property/ Plant/ Equipment Total- Net	634.88	576.42	566.82	569.66
Goodwill Net	57.46	57.46	57.46	57.46
Intangibles Net	1,388.46	1,322.28	671.39	32.11
Long Term Investments	33.68	27.40	17.54	13.09
Note Receivable- Long Term	15.57	29.89	11.95	5.62
Other Long Term Assets Total	10.73	12.38	7.38	7.58
Total Assets	3,994.13	3,553.87	2,607.40	2,238.12
Accounts Payable	356.31	238.65	224.48	186.92
Current Portof LT Debt/ Capital Leases	344.38	145.89	33.94	33.63
Other Currentliabilities Total	167.54	141.87	125.29	118.50
Total Current Liabilities	868.23	554.45	383.72	345.27
Long Term Debt	23.64	383.22	-	-
Capital Lease Obligations	9.64	15.32	20.62	5.14
Total Long Term Debt	33.28	398.54	20.62	5.14
Total Debt	377.66	572.45	54.56	44.99
Deferred Income Tax	149.20	102.82	47.56	56.77
Other Liabilities Total	20.09	17.70	16.90	17.50
Total Liabilities	1,070.80	1,073.52	473.28	428.39
Common Stock Total	15.52	15.48	15.46	15.46
Retained Earnings( Accumulated Deficit)	2,907.81	2,398.76	2,058.17	1,737.60
Total Equity	2,923.33	2,480.35	2,134.12	1,809.72
Total Liabilities Shareholders' Equity	3,994.13	3,553.87	2,607.40	2,238.12
Total Common Shares Outstanding	15.52	15.48	15.46	15.46
Tangible Book Valueper Share Common Eq	95.19	71.12	90.92	111.29
Cash	-	50.02	54.72	25.30
Prepaid Expenses	-	16.70	12.04	12.26
Property/ Plant/ Equipment Total- Gross	-	1,219.91	1,149.74	1,107.78
Accumulated Depreciation Total	-	-643.49	-582.92	-538.12
Accrued Expenses	-	0.03	0.01	0.00
Notes Payable/ Short Term Debt	-	28.02	0.00	6.21
Minority Interest	-	0.00	4.49	3.71
Additional Paid- In Capital	-	69.73	50.77	50.77
Unrealized Gain( Loss)	-	0.35	0.35	0.35
Other Equity Total	-	-3.97	9.38	5.55